ORBIMED ADVISORS LLC Q3 2017 Filing
Filed November 14, 2017
Portfolio Value
$10.5B
Holdings
138
Report Date
Q3 2017
Filing Type
13F-HR
All Holdings (138 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ALXNALEXION PHARMACEUTICALS INC | 3,645,486 | $511.4B | 4887.56% | |
| 2 | BIIBBIOGEN INC | 1,630,000 | $510.4B | 4877.63% | |
| 3 | CELGCELGENE CORP | 3,351,977 | $488.8B | 4671.20% | |
| 4 | BSXBOSTON SCIENTIFIC CORP | 13,397,000 | $390.8B | 3734.68% | |
| 5 | MRKMERCK & CO INC | 5,487,000 | $351.3B | 3357.60% | |
| 6 | VRTXVERTEX PHARMACEUTICALS INC | 2,074,302 | $315.4B | 3013.98% | |
| 7 | PBYIPUMA BIOTECHNOLOGY INC | 2,425,735 | $290.5B | 2776.06% | |
| 8 | LLYLILLY ELI & CO | 3,075,000 | $263.0B | 2513.77% | |
| 9 | REGNREGENERON PHARMACEUTICALS | 572,770 | $256.1B | 2447.46% | |
| 10 | CICIGNA CORPORATION | 1,266,100 | $236.7B | 2261.94% | |
| 11 | AMGNAMGEN INC | 1,253,100 | $233.6B | 2232.84% | |
| 12 | AG8AGILENT TECHNOLOGIES INC | 3,638,900 | $233.6B | 2232.62% | |
| 13 | —WRIGHT MED GROUP N V | 8,946,234 | $231.4B | 2211.81% | |
| 14 | —AETNA INC NEW | 1,396,500 | $222.1B | 2122.14% | |
| 15 | CLVSEURCLOVIS ONCOLOGY INC | 2,388,670 | $196.8B | 1881.02% | |
| 16 | INCYINCYTE CORP | 1,676,000 | $195.7B | 1869.84% | Put |
| 17 | ELVANTHEM INC | 927,618 | $176.1B | 1683.29% | |
| 18 | —CLEMENTIA PHARMACEUTICALS IN | 10,425,225 | $176.1B | 1682.77% | |
| 19 | ABBVABBVIE INC | 1,965,000 | $174.6B | 1668.70% | |
| 20 | ARRYEURARRAY BIOPHARMA INC | 14,182,900 | $174.4B | 1667.18% | |
| 21 | —LOXO ONCOLOGY INC | 1,728,000 | $159.2B | 1521.27% | |
| 22 | GILDGILEAD SCIENCES INC | 1,928,000 | $156.2B | 1492.83% | |
| 23 | EWEDWARDS LIFESCIENCES CORP | 1,390,700 | $152.0B | 1452.79% | |
| 24 | JNJJOHNSON & JOHNSON | 1,124,400 | $146.2B | 1397.03% | |
| 25 | —IMMUNOMEDICS INC | 9,996,816 | $139.8B | 1335.60% | |
| 26 | ONCBEIGENE LTD | 1,313,788 | $135.9B | 1299.00% | |
| 27 | ALNYALNYLAM PHARMACEUTICALS INC | 1,084,800 | $127.5B | 1218.04% | |
| 28 | ASNDASCENDIS PHARMA A S | 3,367,315 | $122.1B | 1166.55% | |
| 29 | —AUDENTES THERAPEUTICS INC | 4,129,638 | $115.7B | 1105.44% | |
| 30 | —MYLAN N V | 3,601,100 | $113.0B | 1079.60% | |
| 31 | JAZZJAZZ PHARMACEUTICALS PLC | 749,200 | $109.6B | 1047.14% | |
| 32 | SEMSELECT MED HLDGS CORP | 5,578,500 | $107.1B | 1023.60% | |
| 33 | TMOTHERMO FISHER SCIENTIFIC INC | 534,200 | $101.1B | 965.91% | |
| 34 | —JUNO THERAPEUTICS INC | 2,041,608 | $91.6B | 875.27% | |
| 35 | IRWDIRONWOOD PHARMACEUTICALS INC | 5,759,200 | $90.8B | 867.97% | |
| 36 | PFEPFIZER INC | 2,458,800 | $87.8B | 838.88% | |
| 37 | CRVSCORVUS PHARMACEUTICALS INC | 5,379,349 | $85.7B | 819.46% | |
| 38 | ILMNILLUMINA INC | 398,500 | $79.4B | 758.62% | |
| 39 | —ALLERGAN PLC | 373,590 | $76.6B | 731.73% | |
| 40 | —SHIRE PLC | 499,908 | $76.6B | 731.63% | Put |
| 41 | —MAGELLAN HEALTH INC | 882,600 | $76.2B | 727.92% | |
| 42 | UNHUNITEDHEALTH GROUP INC | 380,000 | $74.4B | 711.24% | |
| 43 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 2,393,635 | $74.3B | 710.28% | |
| 44 | UHSUNIVERSAL HLTH SVCS INC | 669,000 | $74.2B | 709.29% | |
| 45 | AERIEURAERIE PHARMACEUTICALS INC | 1,438,182 | $69.9B | 667.98% | |
| 46 | BMRNBIOMARIN PHARMACEUTICAL INC | 743,900 | $69.2B | 661.66% | |
| 47 | MDTMEDTRONIC PLC | 879,000 | $68.4B | 653.30% | |
| 48 | —BLUEBIRD BIO INC | 481,946 | $66.2B | 632.61% | |
| 49 | NTLAINTELLIA THERAPEUTICS INC | 2,662,180 | $66.2B | 632.23% | |
| 50 | BMYBRISTOL MYERS SQUIBB CO | 1,024,700 | $65.3B | 624.19% | Call |
| 51 | —ALLERGAN PLC | 88,200 | $65.1B | 621.92% | |
| 52 | SYKSTRYKER CORP | 421,000 | $59.8B | 571.40% | |
| 53 | ISRGINTUITIVE SURGICAL INC | 56,400 | $59.0B | 563.73% | |
| 54 | —ACHILLION PHARMACEUTICALS IN | 13,062,900 | $58.7B | 560.52% | |
| 55 | IM8NINSMED INC | 1,875,016 | $58.5B | 559.25% | |
| 56 | —GW PHARMACEUTICALS PLC | 561,071 | $56.9B | 544.19% | |
| 57 | IARTINTEGRA LIFESCIENCES HLDGS C | 1,090,910 | $55.1B | 526.28% | |
| 58 | —MALLINCKRODT PUB LTD CO | 1,472,700 | $55.0B | 525.96% | |
| 59 | INSYEURINSYS THERAPEUTICS INC NEW | 6,171,440 | $54.8B | 523.73% | |
| 60 | VRAYQVIEWRAY INC | 9,458,567 | $54.5B | 520.66% | |
| 61 | KALAKALA PHARMACEUTICALS INC | 2,375,279 | $54.3B | 518.46% | |
| 62 | GLPGGALAPAGOS NV | 523,790 | $53.3B | 509.34% | |
| 63 | IOVAIOVANCE BIOTHERAPEUTICS INC | 6,425,626 | $49.8B | 475.92% | |
| 64 | NVROEURNEVRO CORP | 494,900 | $45.0B | 429.83% | |
| 65 | EHTHEHEALTH INC | 1,834,700 | $43.8B | 418.88% | |
| 66 | —RADIUS HEALTH INC | 1,122,800 | $43.3B | 413.65% | |
| 67 | PIRSPIERIS PHARMACEUTICALS INC | 7,259,620 | $41.8B | 399.62% | |
| 68 | IMGNEURIMMUNOGEN INC | 5,450,581 | $41.7B | 398.49% | |
| 69 | —SYNERGY PHARMACEUTICALS DEL | 13,621,443 | $39.5B | 377.51% | |
| 70 | —MOMENTA PHARMACEUTICALS INC | 2,109,068 | $39.0B | 372.89% | |
| 71 | —SPARK THERAPEUTICS INC | 430,016 | $38.3B | 366.41% | |
| 72 | —DERMIRA INC | 1,418,873 | $38.3B | 366.12% | |
| 73 | NVLSEURALPINE IMMUNE SCIENCES INC | 3,298,516 | $38.3B | 365.67% | |
| 74 | SELBUSDSELECTA BIOSCIENCES INC | 1,842,797 | $33.6B | 321.40% | |
| 75 | —DIMENSION THERAPEUTICS INC | 5,397,698 | $32.4B | 309.51% | |
| 76 | —NABRIVA THERAPEUTICS PLC | 3,919,600 | $32.1B | 306.79% | |
| 77 | GKOSGLAUKOS CORP | 836,500 | $27.6B | 263.81% | |
| 78 | ASMBASSEMBLY BIOSCIENCES INC | 748,026 | $26.1B | 249.63% | |
| 79 | —SYNLOGIC INC | 1,314,996 | $25.0B | 238.97% | |
| 80 | ICPTUSDINTERCEPT PHARMACEUTICALS IN | 386,380 | $22.4B | 214.31% | |
| 81 | —DBV TECHNOLOGIES S A | 512,900 | $21.8B | 208.02% | |
| 82 | —OBSEVA SA | 2,605,531 | $21.2B | 202.69% | |
| 83 | NTRANATERA INC | 1,576,190 | $20.3B | 194.16% | |
| 84 | —ENVISION HEALTHCARE CORP | 440,700 | $19.8B | 189.31% | |
| 85 | SVASINOVAC BIOTECH LTD | 2,667,500 | $18.8B | 179.72% | |
| 86 | ZLABZAI LAB LTD | 658,160 | $17.8B | 169.82% | |
| 87 | NBIXNEUROCRINE BIOSCIENCES INC | 284,841 | $17.5B | 166.81% | |
| 88 | VNDAVANDA PHARMACEUTICALS INC | 967,859 | $17.3B | 165.57% | |
| 89 | XNCRXENCOR INC | 747,244 | $17.1B | 163.68% | |
| 90 | CTIC1USDCTI BIOPHARMA CORP | 5,000,000 | $15.9B | 152.43% | |
| 91 | NVONOVO-NORDISK A S | 330,000 | $15.9B | 151.86% | |
| 92 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 1,914,660 | $15.7B | 149.86% | |
| 93 | HCAHCA HEALTHCARE INC | 187,400 | $14.9B | 142.54% | |
| 94 | CHRSCOHERUS BIOSCIENCES INC | 1,079,700 | $14.4B | 137.75% | |
| 95 | NVTA1EURINVITAE CORP | 1,518,197 | $14.2B | 135.95% | |
| 96 | —STEADYMED LTD | 4,246,196 | $14.2B | 135.94% | |
| 97 | —WRIGHT MED GROUP N V | 8,713,088 | $13.5B | 129.06% | |
| 98 | —NOVUS THERAPEUTICS INC | 2,537,110 | $13.2B | 126.32% | |
| 99 | NUVAGBPNUVASIVE INC | 220,700 | $12.2B | 116.97% | |
| 100 | —AEGERION PHARMACEUTICALS INC | 15,000,000 | $12.2B | 116.12% |
Page 1 of 2Next